# FactSet Research Systems Inc. (FDS) — Investment Thesis

**Exchange:** NASDAQ  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-18  
**Tier:** Free primer (steps 1 & 3 of 19)  
**Sibling pages:** /stocks/FDS/financials · /stocks/FDS/memo

> This page shows the free thesis context (business model + recent catalysts).
> The full investment thesis (moat analysis, DCF, scenarios, risk register) is available
> via GET /api/v1/research/FDS/memo ($2.00, Bearer token).

## Business Model

---
ticker: FDS
step: 01
generated: 2026-05-13
source: quick-research
---

### FactSet Research Systems Inc. (FDS) — Business Overview

*Note: FactSet's fiscal year ends August 31.*

#### Business Description
FactSet is a financial data and analytics platform serving investment professionals — portfolio managers, equity researchers, investment bankers, and risk managers — with integrated data feeds, analytics tools, and workflow automation. Founded in 1978, the company has achieved **46 consecutive years of revenue growth** through a subscription-based model with extremely high switching costs. FY2025 revenue was $2.322B (+5.4%); organic ASV $2.37B (+5.7%). The company is navigating significant AI disruption risk — stock declined ~54.5% from March 2025 highs as AI-native competitors and Bloomberg/LSEG/Refinitiv AI features threatened the traditional financial data platform moat.

#### Revenue Model
Almost entirely subscription-based: **Annual Subscription Value (ASV)** is the key metric — contractual annual recurring revenue from financial professionals paying for platform access. ASV grows through (1) pricing increases (historically CPI+ for renewing clients), (2) net new user adds, and (3) upsell to premium data modules. Revenue persistence is exceptional — once a research analyst builds their workflow in FactSet (models, watchlists, screeners, report templates), switching to Bloomberg or Refinitiv requires rebuilding everything and retraining entire teams. Professional services (implementation, consulting) is ~5–10% of revenue.

#### Products & Services
- **FactSet Workstation** — core platform: integrated data (fundamentals, pricing, estimates, news), analytics, charting, portfolio analytics for buy/sell-side professionals
- **Cobalt** — private markets data platform (PE fund performance, portfolio company data); growing segment targeting PE funds
- **CUSIP Global Services** — operator of the CUSIP numbering system (universal security identifier for all US securities); regulatory/financial industry utility; very sticky revenue
- **Vermilion Reporting Suite** — client reporting and data distribution automation for wealth managers and asset managers
- **Portware / LiquidityBook** — execution management system (EMS) for trading desks; cloud-native (LiquidityBook acquired Feb 2025)
- **GenAI Tools** — AI-assisted research tools embedded in the workstation; competitive response to Bloomberg/LSEG AI initiatives
- **Data Feeds & APIs** — institutional data distribution for quant funds, fintech developers, data science teams

#### Customer Base & Go-to-Market
Buy-side investment managers (largest segment), sell-side research analysts, investment banks (Barclays multiyear deal Jan 2026), hedge funds, private equity firms, wealth management firms, and corporations. Sold through direct enterprise sales with multi-year contracts. Pricing is per-user-per-year; enterprise deals include volume discounts.

#### Competitive Position
FactSet competes directly with Bloomberg (dominant in sell-side/trading desks), LSEG/Refinitiv (Eikon/Workspace), and S&P Market Intelligence. FactSet historically occupied the buy-side/investment management sweet spot where Bloomberg was less dominant — but AI is eroding this positioning. The key moat: CUSIP operator status (regulatory utility), workflow lock-in, and 46-year data history that AI models cannot easily replicate or replace. The Barclays multiyear win suggests sell-side penetration is possible alongside buy-side strength.

#### Key Facts
- Founded: 1978 (Norwalk, Connecticut)
- Headquarters: Norwalk, Connecticut (and other locations)
- Employees: ~12,000
- Exchange: NASDAQ
- Sector / Industry: Financials / Financial Data & Analytics
- Market Cap: ~$10–13B (at ~$250–330/share post-selloff)

## Recent Catalysts

---
ticker: FDS
step: 12
generated: 2026-05-13
source: quick-research
---

### FactSet Research Systems Inc. (FDS) — Investment Catalysts & Risks

#### Bull Case Drivers

1. **46-Year Revenue Streak + Workflow Lock-In = Structural Stickiness That AI Cannot Easily Disrupt** — FactSet's 46 consecutive years of revenue growth through multiple technology disruptions (internet, cloud, Bloomberg dominance) suggests the switching costs are more durable than AI bears assume. An investment analyst at a $10B AUM fund who has built their entire research workflow — DCF models, peer comparison screens, news alerting, portfolio attribution — in FactSet cannot migrate to AI-native tools overnight: all those custom reports, integrations, and workflows must be rebuilt. CUSIP (the US securities identifier standard that FactSet operates) is a regulatory utility that AI cannot replace. The Barclays multiyear deal (January 2026) demonstrates sell-side clients are expanding, not retreating.

2. **Private Markets + Execution Management = Two New Revenue Legs Above Core ASV** — FactSet's Cobalt (private capital data) and LiquidityBook (cloud-native execution management) address two large adjacent markets that Bloomberg's traditional strengths don't fully cover: (1) PE/VC fund managers need private company benchmarks, deal flow data, and portfolio company analytics — Cobalt is growing into this $50B+ TAM. (2) Execution management for trading desks was historically dominated by fragmented legacy vendors — LiquidityBook's cloud-native architecture gives FactSet a modern EMS to compete for trading desk contracts alongside the workstation. If these two segments collectively grow to 20%+ of revenue within 3–5 years, they provide a growth offset to any slowdown in core ASV.

3. **Valuation Reset + Q1 FY2026 Margin Strength = Entry Point** — The ~54.5% stock decline from March 2025 highs has reset FactSet's P/E from 40–45x down to 17–22x trailing EPS — a multiple more appropriate for a mature subscription business than a high-growth compounder. At 17–22x earnings for a company with a 32% operating margin, 46-year revenue streak, and 5–8% annual growth, FactSet offers a reasonable risk-reward. Q1 FY2026 showed net margin strength (per Simply Wall St), suggesting the cost structure is improving even as revenue growth moderates. If AI disruption proves more gradual than feared (and FactSet's GenAI investments prove successful), the stock could re-rate from 18x toward 25–28x on recovering growth confidence.

#### Bear Case Risks

1. **AI Disruption + Bloomberg AI + LLM Equity Research = Structural Threat to Core Workflow** — The fundamental bear case is that large language models (GPT-4o, Claude) are replacing the need for equity analysts to manually build financial models and research reports in a traditional workstation interface. If AI assistants can pull financials, run screening, generate research summaries, and execute trades through natural language commands — reducing the 12 FactSet seats a typical fund needs to 4–5 — ASV per client declines even if FactSet builds its own AI tools. Bloomberg's AI features (August 2024 Copilot launch), LSEG's AI integrations, and AI-native research startups all compete for analyst workflow time. BofA's Underperform at $195 (vs. ~$300) explicitly models this disruption scenario materializing.

2. **ASV Growth Deceleration + Pricing Power Erosion = Revenue Growth Ceiling** — Organic ASV growth decelerated to 5.7% in FY2025 from higher levels in prior years, with management acknowledging that slower CPI limits their traditional CPI-linked price increase playbook. Buy-side clients (asset managers, hedge funds) are under AUM pressure from fee compression and passive investing migration — when a $5B AUM fund shrinks to $3B due to outflows, they renegotiate or cancel FactSet seats. If buy-side AUM continues declining through passive migration, FactSet's per-seat pricing power diminishes. The combination of lower price increases + lower seat count at shrinking clients + AI-native alternatives = ASV growth potentially settling at 3–5% rather than the 7–10% of prior years.

3. **Elevated Debt + M&A Integration Risk = Balance Sheet Overhang** — LiquidityBook and LogoIntern acquisitions added to FactSet's already elevated debt load from prior acquisitions (CUSIP, Portware, Cobalt). Integration of cloud-native EMS (LiquidityBook) alongside a traditional workstation platform requires significant engineering effort. If the acquisitions underperform (LiquidityBook fails to win trading desk mandates; LogoIntern doesn't add meaningful ASV), the acquisition cost was wasted capital that diluted returns. The combination of high debt + uncertain acquisition ROI + decelerating organic growth creates balance sheet risk if growth continues to disappoint.

#### Upcoming Events
- **Q2 FY2026 earnings** (Feb 2026): ASV growth rate — is 5.7% the floor or is it decelerating further?
- **Barclays deal contribution**: When does the multiyear arrangement translate into ASV?
- **GenAI product launches**: Customer adoption rates for AI-assisted research tools
- **LiquidityBook deals**: Any new EMS contract wins at major trading desks?
- **Cobalt private markets**: Revenue contribution and growth trajectory
- **EBITDA margin**: Can FDS expand margins through automation even with decelerating revenue?

#### Analyst Sentiment
Hold consensus with wide valuation debate: avg PT $292.40 (range $195 BofA Underperform to $425 bull); Hold consensus (stock down 54.5% from highs). BofA's Underperform reflects the AI disruption scenario. Bulls point to 46-year streak, switching costs, CUSIP utility, and Barclays win. The stock is at an inflection: if FactSet's AI investments prove sticky and ASV growth re-accelerates toward 7–8%, the current 18–22x P/E is cheap. If AI disruption materializes in 2026 ASV, the stock could compress further.

#### Research Date
Generated: 2026-05-13

## Full Investment Thesis (Premium)

The full research tier adds these thesis-critical dimensions:

- Moat Analysis — durable competitive advantages, switching costs, network effects
- Investment Thesis — variant perception, what has to be true, why market may be wrong
- Bull / Base / Bear Scenarios — probability weights, catalysts, price targets
- Risk Register — macro, competitive, execution, regulatory risks with materiality ratings
- Management Quality — capital allocation track record, incentive alignment
- DCF Valuation — 10-year model with sensitivity matrix

**API endpoint:** GET /api/v1/research/FDS/memo

## Navigation

- Overview: /stocks/FDS
- Financials: /stocks/FDS/financials
- Thesis (this page): /stocks/FDS/thesis
- Investment Memo: /stocks/FDS/memo
- Coverage universe: /stocks